NPI: 1679532303 · MOBILE, AL 36603 · Dentist · NPI assigned 03/21/2006
Authorized official WHITE, CHARLES controls 19+ related entities in our dataset. Read more
| Authorized Official | WHITE, CHARLES (CEO) |
| NPI Enumeration Date | 03/21/2006 |
Other providers sharing the same authorized official: WHITE, CHARLES
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 91,346 | $3.88M |
| 2019 | 96,348 | $4.37M |
| 2020 | 74,533 | $3.82M |
| 2021 | 84,798 | $4.32M |
| 2022 | 93,709 | $3.95M |
| 2023 | 68,572 | $3.57M |
| 2024 | 46,584 | $2.82M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| T1015 | Clinic visit/encounter, all-inclusive | 283,048 | 174,620 | $26.42M |
| D9430 | 1,284 | 707 | $104K | |
| 90651 | 2,620 | 2,473 | $22K | |
| 90715 | 2,089 | 1,860 | $21K | |
| 90734 | 2,961 | 2,708 | $20K | |
| 90686 | 1,919 | 1,765 | $19K | |
| 90670 | 2,518 | 2,276 | $19K | |
| 90633 | 2,209 | 2,033 | $16K | |
| 90710 | 1,856 | 1,746 | $13K | |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 72,261 | 51,827 | $11K |
| 90680 | 1,151 | 1,058 | $8K | |
| 90698 | 1,114 | 1,016 | $8K | |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 64,595 | 47,532 | $7K |
| 90648 | 1,006 | 923 | $7K | |
| 90688 | 615 | 511 | $7K | |
| 90696 | 924 | 875 | $6K | |
| 90744 | 677 | 617 | $5K | |
| 90620 | 586 | 525 | $4K | |
| 90723 | 538 | 489 | $4K | |
| 90656 | 409 | 328 | $2K | |
| 90700 | 295 | 279 | $2K | |
| 90671 | 234 | 206 | $2K | |
| 90658 | 161 | 137 | $1K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 18,284 | 12,847 | $442.79 |
| 90697 | 40 | 39 | $312.00 | |
| 90716 | 26 | 24 | $184.00 | |
| 90732 | 20 | 12 | $168.00 | |
| 90685 | 20 | 18 | $144.00 | |
| 90657 | 15 | 14 | $104.00 | |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 1,136 | 1,038 | $19.94 |
| 90687 | 69 | 63 | $16.00 | |
| 99173 | 5,956 | 4,737 | $9.03 | |
| 81003 | 2,086 | 1,244 | $3.00 | |
| 92551 | 6,321 | 4,869 | $0.00 | |
| 3074F | 1,850 | 1,272 | $0.00 | |
| 3061F | 361 | 269 | $0.00 | |
| 3008F | 4,027 | 2,780 | $0.00 | |
| 1126F | 1,135 | 1,035 | $0.00 | |
| 99239 | Hospital discharge day management, more than 30 minutes | 584 | 428 | $0.00 |
| D0140 | Limited oral evaluation - problem focused | 158 | 102 | $0.00 |
| G0467 | Federally qualified health center (fqhc) visit, established patient; a medically-necessary, face-to-face encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a fqhc visit | 685 | 634 | $0.00 |
| 1036F | 1,617 | 1,462 | $0.00 | |
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | 2,716 | 2,272 | $0.00 |
| 82962 | 2,678 | 2,118 | $0.00 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 353 | 246 | $0.00 |
| 99232 | Subsequent hospital care, per day, moderate complexity | 4,890 | 1,070 | $0.00 |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 103 | 92 | $0.00 |
| 1170F | 334 | 273 | $0.00 | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 163 | 148 | $0.00 |
| 83036 | Hemoglobin; glycosylated (A1C) | 610 | 490 | $0.00 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 415 | 310 | $0.00 |
| 36415 | Collection of venous blood by venipuncture | 327 | 264 | $0.00 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 344 | 285 | $0.00 |
| 92342 | 78 | 63 | $0.00 | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 316 | 179 | $0.00 |
| 1125F | 201 | 192 | $0.00 | |
| 3079F | 289 | 191 | $0.00 | |
| 1111F | 103 | 93 | $0.00 | |
| 0012A | 103 | 90 | $0.00 | |
| D0272 | Bitewings - two radiographic images | 109 | 84 | $0.00 |
| 0072A | 52 | 28 | $0.00 | |
| D0120 | Periodic oral evaluation - established patient | 49 | 30 | $0.00 |
| 91307 | 56 | 42 | $0.00 | |
| 3075F | 12 | 12 | $0.00 | |
| 36416 | 40 | 26 | $0.00 | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 193 | 137 | $0.00 |
| D1206 | Topical application of fluoride varnish | 94 | 48 | $0.00 |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 13 | 13 | $0.00 |
| 0011A | 91 | 85 | $0.00 | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | 21 | 15 | $0.00 |
| D0150 | Comprehensive oral evaluation - new or established patient | 115 | 74 | $0.00 |
| 1034F | 16 | 15 | $0.00 | |
| 99000 | 263 | 208 | $0.00 | |
| 87807 | 42 | 26 | $0.00 | |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 74 | 56 | $0.00 |
| 80053 | Comprehensive metabolic panel | 24 | 17 | $0.00 |
| 84443 | Thyroid stimulating hormone (TSH) | 22 | 12 | $0.00 |
| 3078F | 1,588 | 1,097 | $0.00 | |
| 99233 | Prolong inpt eval add15 m | 11,697 | 2,420 | $0.00 |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | 3,738 | 3,168 | $0.00 |
| 99238 | Hospital discharge day management, 30 minutes or less | 1,672 | 1,288 | $0.00 |
| 92015 | Determination of refractive state | 6,177 | 5,482 | $0.00 |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 3,017 | 2,234 | $0.00 |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 332 | 281 | $0.00 |
| 1159F | 1,179 | 1,098 | $0.00 | |
| 81025 | 984 | 655 | $0.00 | |
| 1160F | 1,187 | 1,099 | $0.00 | |
| 92340 | Fitting of spectacles, except for aphakia; monofocal | 2,376 | 2,056 | $0.00 |
| 82947 | 802 | 644 | $0.00 | |
| 99203 | Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 542 | 396 | $0.00 |
| 99222 | Initial hospital care, per day, moderate complexity | 797 | 583 | $0.00 |
| 99223 | Prolong inpt eval add15 m | 1,652 | 1,244 | $0.00 |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 2,470 | 1,846 | $0.00 |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 2,784 | 2,182 | $0.00 |
| 99215 | Prolong outpt/office vis | 2,313 | 1,777 | $0.00 |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 1,115 | 865 | $0.00 |
| 92341 | 211 | 194 | $0.00 | |
| 4274F | 26 | 25 | $0.00 | |
| 80074 | 109 | 80 | $0.00 | |
| 99231 | Subsequent hospital care, per day, straightforward or low complexity | 147 | 56 | $0.00 |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 163 | 148 | $0.00 |
| G0511 | Rural health clinic or federally qualified health center (rhc or fqhc) only, general care management, 20 minutes or more of clinical staff time for chronic care management services or behavioral health integration services directed by an rhc or fqhc practitioner (physician, np, pa, or cnm), per calendar month | 1,104 | 999 | $0.00 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 306 | 258 | $0.00 |
| 90472 | Immunization administration, each additional vaccine (list separately) | 220 | 171 | $0.00 |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 242 | 181 | $0.00 |
| 1158F | 20 | 15 | $0.00 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 298 | 210 | $0.00 |
| 87400 | 87 | 62 | $0.00 | |
| 0071A | 75 | 47 | $0.00 | |
| 81002 | 81 | 56 | $0.00 | |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | 315 | 207 | $0.00 |
| D0190 | 61 | 30 | $0.00 | |
| 3062F | 360 | 268 | $0.00 | |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | 63 | 56 | $0.00 |
| 92133 | 21 | 13 | $0.00 | |
| 99204 | Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 46 | 27 | $0.00 |
| 3077F | 90 | 54 | $0.00 | |
| D1120 | Prophylaxis - child | 175 | 145 | $0.00 |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 157 | 110 | $0.00 |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 29 | 27 | $0.00 |
| 86328 | 26 | 13 | $0.00 | |
| D0145 | Oral evaluation for a patient under three years of age | 45 | 16 | $0.00 |
| 4004F | 106 | 102 | $0.00 | |
| D0220 | Intraoral - periapical first radiographic image | 39 | 24 | $0.00 |
| 90837 | Psychotherapy, 53 minutes with patient | 22 | 15 | $0.00 |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | 22 | 16 | $0.00 |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 17 | 12 | $0.00 |
| 4040F | 16 | 13 | $0.00 |